Investor's Business Daily
financeLeft
Biohaven Plummets, A Boon For Rival Xenon, On A Surprise Seizure Setbacktranslating…
Biohaven stock plummeted Thursday after the company paused enrollment in a midstage study of its seizure treatment due to safety concerns.
The post Biohaven Plummets, A Boon For Rival Xenon, On A Surprise Seizure Setback appeared first on Investor's Business Daily.
Keywords#Biohaven#Seizure#Biohaven Plummets#Seizure Setback#Surprise Seizure